Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYT107 in HIV-related Progressive Multifocal Leukoencephalopathy
2012-000725-41Phase 2Terminated
- Sponsor
- Cytheris SA
- Start
- Sep 2012
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial in progressive multifocal leukoencephalopathy (PML) and human immunodeficiency virus infection (HIV) comparing CYT107 with Placebo (2 arms). Primary endpoint: JC virus clearance from cerebrospinal fluid at Month 3. Started Sep 2012; status: terminated.
02
Drugs
recombinant human interleukin-7
03
Conditions
progressive multifocal leukoencephalopathy (PML)human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2012-000725-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000725-41.